Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

A phase 2 trial shows promising results for pembrolizumab combined with cisplatin and radiation in treating unresectable ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...